Paratek Pharmaceuticals Broadens Clinical Profile of NUZYRA™ (Omadacycline) with New ECCMID 2019 Data Presentations

    NEXT STORY
    NILE Study Results Demonstrating Guardant360’s High Concordance to Tissue Testing in Advanced NSCLC Published in Clinical Cancer Research
    PREV STORY
    Sprint Through Real-Time Promo Review
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Doctors Administrative Solutions acquires ConXit Technology Group; forms national Health IT & management solutions firm: DAS Health

    Tampa, Fla., Jan. 04, 2016 (GLOBE NEWSWIRE) -- United by a common business culture, ...

    author_avatar
    NASDAQ Market News

    Lightlake Therapeutics Inc. Announces Collaboration With NIDA and the Perelman School of Medicine at the University of Pennsylvania

    NEW YORK, Dec. 23, 2015 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a ...

    author_avatar
    NASDAQ Market News

    CareSource Foundation Awards $1.6 Million to Ohio Nonprofit Organizations in 2015

    DAYTON, Ohio, Dec. 21, 2015 (GLOBE NEWSWIRE) -- The CareSource Foundation has announced the ...

    author_avatar
    NASDAQ Market News